RCAD002 / IAVI R002

A phase 1 randomized, placebo-controlled clinical trial to test the safety and immunogenicity of an oral, replicating Ad26 vectored HIV-1 vaccine in healthy adults

We are looking for healthy men and women ages 18-50 years old for a clinical trial of an experimental HIV vaccine given in capsule form.

Note: it is impossible to get HIV infection from the study vaccine.

If you would like to be considered for participation, please complete the form at right.

You may also call 617-735-4610 or email us at cvvrtrials@bidmc.harvard.edu for more information.

We are available to discuss your concerns and answer your questions.